Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
CA Regulators Complete Review of Wildfire Risk Model California’s Department of Insurance has completed a review of the state’s first wildfire catastrophe model, which property/casualty insurers...
Trump Administration’s ‘AI Action Plan’ Targets State AI Regulation The Trump administration released an “AI Action Plan,” aimed at speeding the development of artificial...
In the span of just 36 days this spring and summer, the number of states offering unemployment benefits to striking workers doubled—to four. New Jersey was the first to offer such benefits, beginning...
Developing Anti-‘Debanking’ Trend in Red States? A new front appears to have opened in the ongoing battle over environmental, social and governance (ESG) investing. In March Idaho Gov. Brad...
FL Requests Medicaid Waiver to Bolster Health Workforce Florida is seeking a federal waiver to use Medicaid funding to expand its health care workforce, a plan that could be adopted by other states....
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Connecticut Gov. Ned Lamont (D) signed legislation (HB 7192) allowing the state to seek to hire a generic drug-manufacturer to make cheap versions of Ozempic, Wegovy and other GLP-1 drugs the state could then provide to those covered by Medicaid or the state employees’ health plan. No other state has a law in place for such drugs (NEW HAVEN REGISTER)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.